Our Science – Day Website
Patricia M. Day, Ph.D.
Selected Publications |
| 1)
Day PM, Thompson CD, Buck CB, Pang YY, Lowy DR, Schiller JT. Neutralization of human papillomavirus with monoclonal antibodies reveals different mechanisms of inhibition. J. Virol. 81: 8784-92, 2007. [Journal] |
| 2)
Kämper N, Day PM, Nowak T, Selinka HC, Florin L, Bolscher J, Hilbig L, Schiller JT, Sapp M. A membrane-destabilizing peptide in capsid protein L2 is required for egress of papillomavirus genomes from endosomes. J. Virol. 80: 759-68, 2006. [Journal] |
| 3)
Richards RM, Lowy DR, Schiller JT, Day PM. Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection. Proc. Natl. Acad. Sci. U.S.A. 103: 1522-7, 2006. [Journal] |
| 4)
Buck CB, Day PM, Thompson CD, Lubkowski J, Lu W, Lowy DR, Schiller JT. Human alpha-defensins block papillomavirus infection. Proc. Natl. Acad. Sci. U.S.A. 103: 1516-21, 2006. [Journal] |
| 5)
Day PM, Baker CC, Lowy DR, Schiller JT. Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression. Proc. Natl. Acad. Sci. U.S.A. 101: 14252-7, 2004. [Journal] |
| 6)
Yang R, Day PM, Yutzy WH, Lin KY, Hung CF, Roden RB. Cell surface-binding motifs of L2 that facilitate papillomavirus infection. J. Virol. 77: 3531-41, 2003. [Journal] |
| 7)
Lenz P, Thompson CD, Day PM, Bacot SM, Lowy DR, Schiller JT. Interaction of papillomavirus virus-like particles with human myeloid antigen-presenting cells. Clin. Immunol. 106: 231-7, 2003. [Journal] |
| 8)
Day PM, Lowy DR, Schiller JT. Papillomaviruses infect cells via a clathrin-dependent pathway. Virology. 307: 1-11, 2003. [Journal] |
| 9)
Young PJ, Day PM, Zhou J, Androphy EJ, Morris GE, Lorson CL. A direct interaction between the survival motor neuron protein and p53 and its relationship to spinal muscular atrophy. J. Biol. Chem. 277: 2852-9, 2002. [Journal] |
| 10)
Okun MM, Day PM, Greenstone HL, Booy FP, Lowy DR, Schiller JT, Roden RB. L1 interaction domains of papillomavirus l2 necessary for viral genome encapsidation. J. Virol. 75: 4332-42, 2001. [Journal] |
| 11)
Lenz P, Day PM, Pang YY, Frye SA, Jensen PN, Lowy DR, Schiller JT. Papillomavirus-like particles induce acute activation of dendritic cells. J. Immunol. 166: 5346-55, 2001. [Journal] |
| 12)
Roden RB, Day PM, Bronzo BK, Yutzy WH, Yang Y, Lowy DR, Schiller JT. Positively charged termini of the L2 minor capsid protein are necessary for papillomavirus infection. J. Virol. 75: 10493-7, 2001. [Journal] |
| 13)
Fedele M, Benvenuto G, Pero R, Majello B, Battista S, Lembo F, Vollono E, Day PM, Santoro M, Lania L, Bruni CB, Fusco A, Chiariotti L. A novel member of the BTB/POZ family, PATZ, associates with the RNF4 RING finger protein and acts as a transcriptional repressor. J. Biol. Chem. 275: 7894-901, 2000. [Journal] |
| 14)
Antón LC, Schubert U, Bacík I, Princiotta MF, Wearsch PA, Gibbs J, Day PM, Realini C, Rechsteiner MC, Bennink JR, Yewdell JW. Intracellular localization of proteasomal degradation of a viral antigen. J. Cell Biol. 146: 113-24, 1999. [Journal] |
| 15)
Day PM, Roden RB, Lowy DR, Schiller JT. The papillomavirus minor capsid protein, L2, induces localization of the major capsid protein, L1, and the viral transcription/replication protein, E2, to PML oncogenic domains. J. Virol. 72: 142-50, 1998. [Journal] |
| 16)
Day PM, Yewdell JW, Porgador A, Germain RN, Bennink JR. Direct delivery of exogenous MHC class I molecule-binding oligopeptides to the endoplasmic reticulum of viable cells. Proc. Natl. Acad. Sci. U.S.A. 94: 8064-9, 1997. [Journal] |
| 17)
Day PM, Esquivel F, Lukszo J, Bennink JR, Yewdell JW. Effect of TAP on the generation and intracellular trafficking of peptide-receptive major histocompatibility complex class I molecules. Immunity. 2: 137-47, 1995. [Journal] |
| 18)
Day PM, Frelinger JA. Differential expression of Q4 proteins (Qb-1) in fibroblasts and lymphocytes. J. Immunol. 147: 3427-33, 1991. [Journal] |
| Click Here to View Collapsed Bibliography. |
This page was last updated on 11/6/2007.
